We were delighted to see research into the publicly available skin cancer datasets many use to train AI systems to assess skin cancer published in
26 January 2021 In December, the British Association of Dermatologist (BAD) President’s Bulletin included an article from Dr Rubeta Matin with an update from the
In February 2020, skin cancer researchers released a paper calling into question…
The prospective, diagnostic trial saw DERM, our AI platform, correctly identify all malignant lesions (100% sensitivity) with an average AUROC of 95.8% with 65% specificity versus 70% specificity and a 77% AUROC score demonstrated by the clinical experts. DERM, a CE marked medical device, was developed as a tool to aid clinicians in identifying 11 common skin lesion types, including melanoma.
Well maybe not hats off, we are a company that encourages people to be sun smart after all! So we shall leave our hats on
Is it possible for 16 simple questions to help save your life? Yes, it really is. QIMR Berghofer has released an online test that helps
